E11 E03: Shaping the future of Alzheimer's care: The future of care

In Part 3, Hanna Svanbäck discusses the future of Alzheimer's care over the next five to 10 years, how trial design could be improved and reveals her opinion on the most exciting healthcare innovation on the horizon. Speaker bio Hanna Svanbäck is the Executive Director for Neuroscience, Eli Lilly, overseeing operations in the UK, Ireland and the Nordic countries. Hanna has over 15 years of experience at Lilly and is proud to lead the Neurosciences function given Lilly's long-standing commitment to advancing scientific innovation in this field. Hanna's passion for science and her dedication to utilising innovative approaches to enhance patient care are underpinned by her academic studies in Engineering Genomics and Biotechnology from the University of Umeå, Sweden and University of Manchester.

You can listen to E11 E03: Shaping the future of Alzheimer's care: The future of care online on Radio and Podcast. Open the player on this page to stream the available audio.

E11 E03: Shaping the future of Alzheimer's care: The future of care is an episode from The GOLD Podcast: Weekly Pharma Insights by Alice Watson.

This episode is 07:20 long.

This episode was published on Nov 27, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The GOLD Podcast: Weekly Pharma Insights when more episodes are available from the podcast feed.